Only indication is in the therapy of C. difficile infection, particularly recurrent or severe disease
Possibility of accumulation in severe renal dysfunction; consider checking a vancomycin level in dialysis patients
Avoid concurrent administration of oral vancomycin and bile acid sequestrants (may diminish therapeutic effect of vancomycin).
Concentration: 25 mg/mL (compounded)
Taste: metallic taste
Not all strengths of oral liquids are listed nor are available on IWK formulary
125 mg capsule
Tablets and capsules are preferred especially over an unpleasant tasting liquid.
Not all strengths of oral tablets/capsules are listed and they are not all available on the IWK formulary.
No oral absorption. May increase vancomycin resistant enterococci colonization in the gut
Antimicrobial class: glycopeptide
Average serum half life: serum half life not available due to low systemic absorption
Route of Elimination: Primarily feces as limited absorption